Abstract:Adrenergic receptors (ARs) are members of the super family of G protein-coupled receptors (GPCRs). A large number of small molecular drugs performed their actions on ARs. In this study, two subtypes of ARs affinity chromatographic models have been constructed for investigating the interactions between small molecular compounds and the alpha- and beta-AR subtypes. The alpha-ARs were obtained from HEK 293 cells stably transfected human alpha-ARs on the membrane and the beta-ARs were obtained from lung tissues of rabbits. ARs were purified and immobilized on the surface of macro-pore silica gel by covalent bonds. Then the gel was packed into a stainless steel column (4.6 x 50 mm). Binding abilities between small molecules and immobilized ARs were determined by on-line chromatographic technologies. Preliminary on-line binding studies employing frontal chromatographic techniques were conducted with the known alpha-AR agonist (norepinephrine, NE) and beta-AR antagonist (propranolo). Calculated association constants (K-a) and binding sites (m(Ltot)) values for NE on immobilized alpha-AR were 0.9 x 10(4) L mol(-1) and 5.5 x 10(-7) mol L-1, and on immobilized beta-AR were 0.2 x 10(4) L mol(-1) and 3.3 x 10(-7) mol L-1, respectively. K-a and m(Ltot) values for propranolol on immobilized alpha-AR were 1.1 x 10(3) L mol(-1) and 1.0 x 10(-7) mol L-1, and on immobilized beta-AR were 2.5 x 10(4) L mol(-1) and 5.0 x 10(-7) mol L-1, respectively. Above association values were obviously different, but the changes of their laws were comparatively unanimous: there was stronger binding between small molecular compounds and their immobilized target ARs. The conclusions indicated that the immobilized ARs stationary phases can be used to assess the binding affinities of compounds and screen possible active compounds qualitatively. In addition, this study represented an example of using immobilized subtype ARs in a chromatographic system.

Platform: Voltage-gated K Channels: Activation/ Inactivation Mechanisms

Measuring Receptor–Ligand Binding Kinetics on Cell Surfaces: From Adhesion Frequency to Thermal Fluctuation Methods

The Glycocalyx Promotes Cooperative Binding and Clustering of Adhesion Receptors

Conformational Transitions and Activation of the Adhesion Receptor CD97.

Structures of the human cholecystokinin receptors bound to agonists and antagonists

Characterization of the type A cholecystokinin receptor hormone-binding domain: use of contrasting and complementary methodologies

Molecular Determinants for Ligand Selectivity of the Cell-Free Synthesized Human Endothelin B Receptor

Deciphering specificity and cross-reactivity in tachykinin NK1 and NK2 receptors

Construction of Adrenergic Receptor Subtype Affinity Chromatographic Models for Detection of Ligand–receptor Interactions

Role of lysine187 within the second extracellular loop of the type A cholecystokinin receptor in agonist-induced activation. Use of complementary charge-reversal mutagenesis to define a functionally important interdomain interaction

Biophysical characterization of the CXC chemokine receptor 2 ligands

Mechanisms of peptide agonist dissociation and deactivation of adhesion G-protein-coupled receptors

Structural insights into neurokinin 3 receptor activation by endogenous and analogue peptide agonists

Structural insights into adhesion GPCR ADGRL3 activation and Gq, Gs, Gi, and G12 coupling

Distinct Activation Mechanisms of CXCR4 and ACKR3 Revealed by Single-Molecule Analysis of their Conformational Landscapes

Yeast Two-Hybrid Screening for Proteins That Interact with Alpha(1)-Adrenergic Receptors

Linking non-peptide ligand binding mode to activity at the human cholecystokinin-2 receptor

Estimation of Binding Constants of Receptors and Ligands by Affinity Capillary Electrophoresis.

Elucidation of the molecular basis of cholecystokinin Peptide docking to its receptor using site-specific intrinsic photoaffinity labeling and molecular modeling

Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist

Constrained catecholamines gain β2AR selectivity through allosteric effects on pocket dynamics